11:37 AM EST - Medicenna Therapeutics Corp. : Today announced financial results and corporate highlights for the first quarter ended June 30, 2023. Net loss was $2.9 million or $0.04 per share compared to a net loss of $4.2 million or $0.07 per share for the quarter ended June 30, 2022. Medicenna Therapeutics Corp.
shares T.MDNA are trading down $0.02 at $0.56.
